Generate:Biomedicines | News

Press Releases 06.13.2024
Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D.

Press Releases 04.30.2024
Generate:Biomedicines Expands C‑suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer
Press Releases 01.04.2024
Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42^nd Annual J.P. Morgan Healthcare Conference
Press Releases 11.15.2023
Generate:Biomedicines Announces Publication of its Chroma Model in Nature: A Transformative Generative AI for Protein Therapeutics
Press Releases 11.01.2023
Generate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AI
Press Releases 09.14.2023
Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics
Press Releases 06.26.2023
Generate:Biomedicines Unveils State-of-the-Art CryoEM Laboratory to Accelerate Generative AI Drug Discovery and Development